AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Ralph Lauren Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Scotts Miracle-Gro (SMG) � Form 144 filing: An affiliate plans to sell up to 70,000 common shares, equal to roughly 0.12% of the 57.7 million shares outstanding. The proposed sale, valued at about $4.35 million, is to be executed through Merrill Lynch on the NYSE around 04 Aug 2025.

The shares were originally obtained on 16 Jun 1995 via a partnership contribution. No shares have been sold by the filer in the last three months. The filer certifies that no undisclosed material adverse information is known.

Because the notice covers secondary stock already in issue, there is no dilution to existing holders. However, the transaction may signal the holder’s desire to reduce exposure; investors may watch forthcoming Form 4s for additional insider activity.

Scotts Miracle-Gro (SMG) � Deposito Modulo 144: Un affiliato intende vendere fino a 70.000 azioni ordinarie, pari a circa lo 0,12% delle 57,7 milioni di azioni in circolazione. La vendita proposta, del valore di circa 4,35 milioni di dollari, sarà eseguita tramite Merrill Lynch alla NYSE intorno al 04 agosto 2025.

Le azioni sono state originariamente acquisite il 16 giugno 1995 tramite un conferimento in partnership. Negli ultimi tre mesi il dichiarante non ha venduto azioni. Il dichiarante certifica che non è a conoscenza di informazioni materiali negative non divulgate.

Poiché l’avviso riguarda azioni secondarie già emesse, non vi è alcuna diluizione per gli azionisti esistenti. Tuttavia, l’operazione potrebbe indicare la volontà del detentore di ridurre l’esposizione; gli investitori potrebbero monitorare i prossimi Moduli 4 per eventuali ulteriori movimenti da parte degli insider.

Scotts Miracle-Gro (SMG) � Presentación del Formulario 144: Un afiliado planea vender hasta 70,000 acciones comunes, equivalentes a aproximadamente el 0.12% de las 57.7 millones de acciones en circulación. La venta propuesta, valorada en alrededor de 4.35 millones de dólares, se realizará a través de Merrill Lynch en la NYSE alrededor del 04 de agosto de 2025.

Las acciones fueron originalmente obtenidas el 16 de junio de 1995 mediante una contribución en sociedad. El declarante no ha vendido acciones en los últimos tres meses. El declarante certifica que no posee información adversa material no divulgada.

Dado que el aviso cubre acciones secundarias ya emitidas, no hay »å¾±±ô³Ü³¦¾±Ã³²Ô para los accionistas existentes. Sin embargo, la transacción podría indicar el deseo del titular de reducir su exposición; los inversionistas podrían estar atentos a próximos Formularios 4 para detectar actividad adicional de los insiders.

Scotts Miracle-Gro (SMG) â€� Form 144 제출: í•� 계열사가 ì•� 5,770ë§� ì£� ì¤� ì•� 0.12%ì—� 해당하는 최대 70,000ì£¼ì˜ ë³´í†µì£¼ë¥¼ 매ë„í•� 계íšìž…니ë‹�. 제안ë� ë§¤ë„ ê·œëª¨ëŠ� ì•� 435ë§� 달러ì´ë©°, Merrill Lynchë¥� 통해 NYSEì—서 2025ë…� 8ì›� 4ì¼ê²½ 실행ë� 예정입니ë‹�.

해당 주ì‹ì€ 1995ë…� 6ì›� 16ì� 파트너십 ì¶œìžë¡� ì²˜ìŒ ì·¨ë“ë˜ì—ˆìŠµë‹ˆë‹�. 제출ì¸ì€ 최근 3개월 ë™ì•ˆ 주ì‹ì� 매ë„하지 않았으며, ë¯¸ê³µê°œëœ ì¤‘ëŒ€í•� ë¶€ì •ì  ì •ë³´ê°€ ì—†ìŒì� ì¦ëª…합니ë‹�.

ì� 통지ëŠ� ì´ë¯¸ 발행ë� 2ì°� 주ì‹ì—� ê´€í•� 것으ë¡�, 기존 주주ì—게ëŠ� í¬ì„ 효과가 없습니다. 다만, ì´ë²ˆ 거래ëŠ� 보유ìžê°€ 노출ì� 줄ì´ë ¤ëŠ” ì˜ë„ë¥� 나타ë‚� ìˆ� 있으므ë¡� 투ìžìžë“¤ì€ 향후 Form 4 제출ì� 주시í•� 필요가 있습니다.

Scotts Miracle-Gro (SMG) � Dépôt du formulaire 144 : Un affilié prévoit de vendre jusqu’� 70 000 actions ordinaires, soit environ 0,12 % des 57,7 millions d’actions en circulation. La vente proposée, d’une valeur d’environ 4,35 millions de dollars, sera réalisée via Merrill Lynch à la NYSE aux alentours du 4 août 2025.

Les actions ont été initialement obtenues le 16 juin 1995 par une contribution en partenariat. Le déposant n’a pas vendu d’actions au cours des trois derniers mois. Il certifie qu’il n’a connaissance d’aucune information défavorable importante non divulguée.

Comme cet avis concerne des actions secondaires déjà émises, il n’y a aucune dilution pour les détenteurs actuels. Cependant, cette transaction pourrait indiquer la volonté du détenteur de réduire son exposition ; les investisseurs sont invités à surveiller les prochains formulaires 4 pour détecter toute activité supplémentaire des initiés.

Scotts Miracle-Gro (SMG) � Form 144 Einreichung: Ein verbundenes Unternehmen plant den Verkauf von bis zu 70.000 Stammaktien, was etwa 0,12 % der 57,7 Millionen ausstehenden Aktien entspricht. Der geplante Verkauf im Wert von etwa 4,35 Millionen US-Dollar soll über Merrill Lynch an der NYSE um den 04. August 2025 ausgeführt werden.

Die Aktien wurden ursprünglich am 16. Juni 1995 durch eine Partnerschaftseinlage erworben. Der Einreicher hat in den letzten drei Monaten keine Aktien verkauft. Er bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

Da die Meldung bereits ausgegebene Sekundäraktien betrifft, gibt es keine Verwässerung für bestehende Aktionäre. Die Transaktion könnte jedoch den Wunsch des Inhabers signalisieren, seine Position zu reduzieren; Investoren sollten kommende Formulare 4 auf weitere Insideraktivitäten beobachten.

Positive
  • No dilution: shares already outstanding; capital structure unchanged.
  • Regulatory transparency: timely Rule 144 notice shows adherence to insider-sale disclosure rules.
Negative
  • Potential negative signal: insider disposing of $4.35 m in stock could be interpreted as reduced confidence.
  • Unidentified seller: absence of identity limits ability to gauge strategic importance of the sale.

Insights

TL;DR � Modest insider sale; minor impact given 0.12 % of shares.

70 k shares worth $4.35 m represent a small fraction of SMG’s float. The sale will not alter share count or capital structure, but insider selling can sometimes precede price weakness if viewed as a negative signal. Absent context on the seller’s role or broader selling patterns, I view the filing as informational rather than catalytic.

TL;DR � Insider liquidity event; governance risk minimal.

The Form 144 indicates compliance with Rule 144 disclosure. Lack of recent sales and the small percentage suggest routine diversification. Still, continuous monitoring of subsequent filings is prudent to detect any accelerated insider exit that might raise governance concerns.

Scotts Miracle-Gro (SMG) � Deposito Modulo 144: Un affiliato intende vendere fino a 70.000 azioni ordinarie, pari a circa lo 0,12% delle 57,7 milioni di azioni in circolazione. La vendita proposta, del valore di circa 4,35 milioni di dollari, sarà eseguita tramite Merrill Lynch alla NYSE intorno al 04 agosto 2025.

Le azioni sono state originariamente acquisite il 16 giugno 1995 tramite un conferimento in partnership. Negli ultimi tre mesi il dichiarante non ha venduto azioni. Il dichiarante certifica che non è a conoscenza di informazioni materiali negative non divulgate.

Poiché l’avviso riguarda azioni secondarie già emesse, non vi è alcuna diluizione per gli azionisti esistenti. Tuttavia, l’operazione potrebbe indicare la volontà del detentore di ridurre l’esposizione; gli investitori potrebbero monitorare i prossimi Moduli 4 per eventuali ulteriori movimenti da parte degli insider.

Scotts Miracle-Gro (SMG) � Presentación del Formulario 144: Un afiliado planea vender hasta 70,000 acciones comunes, equivalentes a aproximadamente el 0.12% de las 57.7 millones de acciones en circulación. La venta propuesta, valorada en alrededor de 4.35 millones de dólares, se realizará a través de Merrill Lynch en la NYSE alrededor del 04 de agosto de 2025.

Las acciones fueron originalmente obtenidas el 16 de junio de 1995 mediante una contribución en sociedad. El declarante no ha vendido acciones en los últimos tres meses. El declarante certifica que no posee información adversa material no divulgada.

Dado que el aviso cubre acciones secundarias ya emitidas, no hay »å¾±±ô³Ü³¦¾±Ã³²Ô para los accionistas existentes. Sin embargo, la transacción podría indicar el deseo del titular de reducir su exposición; los inversionistas podrían estar atentos a próximos Formularios 4 para detectar actividad adicional de los insiders.

Scotts Miracle-Gro (SMG) â€� Form 144 제출: í•� 계열사가 ì•� 5,770ë§� ì£� ì¤� ì•� 0.12%ì—� 해당하는 최대 70,000ì£¼ì˜ ë³´í†µì£¼ë¥¼ 매ë„í•� 계íšìž…니ë‹�. 제안ë� ë§¤ë„ ê·œëª¨ëŠ� ì•� 435ë§� 달러ì´ë©°, Merrill Lynchë¥� 통해 NYSEì—서 2025ë…� 8ì›� 4ì¼ê²½ 실행ë� 예정입니ë‹�.

해당 주ì‹ì€ 1995ë…� 6ì›� 16ì� 파트너십 ì¶œìžë¡� ì²˜ìŒ ì·¨ë“ë˜ì—ˆìŠµë‹ˆë‹�. 제출ì¸ì€ 최근 3개월 ë™ì•ˆ 주ì‹ì� 매ë„하지 않았으며, ë¯¸ê³µê°œëœ ì¤‘ëŒ€í•� ë¶€ì •ì  ì •ë³´ê°€ ì—†ìŒì� ì¦ëª…합니ë‹�.

ì� 통지ëŠ� ì´ë¯¸ 발행ë� 2ì°� 주ì‹ì—� ê´€í•� 것으ë¡�, 기존 주주ì—게ëŠ� í¬ì„ 효과가 없습니다. 다만, ì´ë²ˆ 거래ëŠ� 보유ìžê°€ 노출ì� 줄ì´ë ¤ëŠ” ì˜ë„ë¥� 나타ë‚� ìˆ� 있으므ë¡� 투ìžìžë“¤ì€ 향후 Form 4 제출ì� 주시í•� 필요가 있습니다.

Scotts Miracle-Gro (SMG) � Dépôt du formulaire 144 : Un affilié prévoit de vendre jusqu’� 70 000 actions ordinaires, soit environ 0,12 % des 57,7 millions d’actions en circulation. La vente proposée, d’une valeur d’environ 4,35 millions de dollars, sera réalisée via Merrill Lynch à la NYSE aux alentours du 4 août 2025.

Les actions ont été initialement obtenues le 16 juin 1995 par une contribution en partenariat. Le déposant n’a pas vendu d’actions au cours des trois derniers mois. Il certifie qu’il n’a connaissance d’aucune information défavorable importante non divulguée.

Comme cet avis concerne des actions secondaires déjà émises, il n’y a aucune dilution pour les détenteurs actuels. Cependant, cette transaction pourrait indiquer la volonté du détenteur de réduire son exposition ; les investisseurs sont invités à surveiller les prochains formulaires 4 pour détecter toute activité supplémentaire des initiés.

Scotts Miracle-Gro (SMG) � Form 144 Einreichung: Ein verbundenes Unternehmen plant den Verkauf von bis zu 70.000 Stammaktien, was etwa 0,12 % der 57,7 Millionen ausstehenden Aktien entspricht. Der geplante Verkauf im Wert von etwa 4,35 Millionen US-Dollar soll über Merrill Lynch an der NYSE um den 04. August 2025 ausgeführt werden.

Die Aktien wurden ursprünglich am 16. Juni 1995 durch eine Partnerschaftseinlage erworben. Der Einreicher hat in den letzten drei Monaten keine Aktien verkauft. Er bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

Da die Meldung bereits ausgegebene Sekundäraktien betrifft, gibt es keine Verwässerung für bestehende Aktionäre. Die Transaktion könnte jedoch den Wunsch des Inhabers signalisieren, seine Position zu reduzieren; Investoren sollten kommende Formulare 4 auf weitere Insideraktivitäten beobachten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JARRETT VALERIE B

(Last) (First) (Middle)
RALPH LAUREN CORPORATION
650 MADISON AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RALPH LAUREN CORP [ RL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/31/2025 A 581 A (1) 6,080(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of the Issuer's Class A Common Stock issued to the Reporting Person as restricted stock units granted under the Issuer's 2019 Long-Term Stock Incentive Plan. These restricted stock units will vest on July 31, 2026, subject to the Reporting Person's continued service through the 2026 Annual Meeting of Stockholders.
2. The total also reflects a deduction for cash paid in lieu of approximately 0.84 fractional shares of the Issuer's Class A Common Stock upon vesting of previously-granted restricted stock units.
/s/ Avery S. Fischer, Attorney-in-Fact for Valerie Jarrett 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Scotts Miracle-Gro shares are being registered for sale?

Up to 70,000 common shares are covered by this Form 144.

What is the estimated market value of the shares?

The aggregate value stated in the filing is approximately $4.35 million.

When is the planned sale date for SMG stock?

The filer lists an approximate sale date of 04 Aug 2025.

Will this insider sale dilute existing SMG shareholders?

No. The notice relates to resale of already-issued shares, so share count is unaffected.

Where will the shares be sold and through which broker?

Sales are planned on the NYSE via Merrill Lynch, 8890 Lyra Dr, Columbus OH.

When were the shares originally acquired?

They were acquired on 16 Jun 1995 through a partnership contribution.
Ralph Lauren

NYSE:RL

RL Rankings

RL Latest News

RL Latest SEC Filings

RL Stock Data

18.13B
37.14M
3.89%
107.28%
2.81%
Apparel Manufacturing
Men's & Boys' Furnishgs, Work Clothg, & Allied Garments
United States
NEW YORK